Ponikowski P, Kirwan B, Anker SD, et al. Lancet. 2020;396(10266):1895-1904. doi:10.1016/S0140-6736(20)32339-4

Beattie JM, Khatib R, Phillips CJ, Williams SG. Open Heart. 2020;7(1):e001153.
PDF Download

Alcaide-Aldeano A, Garay A, Alcoberro L, et al. J Clin Med. 2020;9(4):1199.
PDF Download

Ponikowski P, Kirwan BA, Anker SD, et al. Eur J Heart Fail. 2019;21(12):1651-1658.
PDF Download

von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. JACC Heart Fail. 2019;7(1):36-46.

Anker SD, Kirwan BA, van Veldhuisen DJ, et al. Eur J Heart Fail. 2018;20(1):125-133.
PDF Download

McDonagh T, Damy T, Doehner W, et al. Eur J Heart Fail. 2018;20(12):1664-1672.
PDF Download

Lewis GD, Malhotra R, Hernandez AF, et al. JAMA. 2017;317(19):1958-1966.
PDF Download

van Veldhuisen DJ, Ponikowski P, van der Meer P, et al. Circulation. 2017;136(15):1374-1383.
PDF Download

Ferreira JP, Butler J, Rossignol P, et al. Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(22):2836-2850. doi:10.1016/j.jacc.2020.04.021

Slides from a panel discussion on new data from AFFIRM-AHF showing reductions in rehospitalization when correcting iron deficiency in patients stabilized after an episode of acute heart failure.
PDF Download

Slides from a panel discussion on changes to integrate into practice based on new data from AFFIRM-AHF.
PDF Download

Slides from a podcast discussing when patients with heart failure should be screened and how to best treat those with iron deficiency.
PDF Download

Piña IL, Yuan J, Ackourey G, Ventura H. Effect of patiromer on serum potassium in hyperkalemic patients with heart failure: Pooled analysis of 3 randomized trials. Prog Cardiovasc Dis. 2020;63(5):656-661. doi:10.1016/j.pcad.2020.09.007

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. doi:10.1093/eurheartj/ehab368

McEwan P, Ponikowski P, Davis JA, et al. Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF [published online ahead of print, 2021 Jun 30]. Eur J Heart Fail. 2021;10.1002/ejhf.2270. doi:10.1002/ejhf.2270

Jankowska EA, Kirwan BA, Kosiborod M, et al. The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study [published online ahead of print, 2021 Jun 3]. Eur Heart J. 2021;42(31):3011-3020. doi:10.1093/eurheartj/ehab234

Bakris GL, Woods SD, Alvarez PJ, Arthur SP, Kumar R. Hyperkalemia Management in Older Adults With Diabetic Kidney Disease Receiving Renin-Angiotensin-Aldosterone System Inhibitors: A Post Hoc Analysis of the AMETHYST-DN Clinical Trial. Kidney Med. 2021;3(3):360-367.e1. Published 2021 Mar 13. doi:10.1016/j.xkme.2021.01.005

A 3D mechanism of action animation examining the relationship between iron deficiency, anemia, and heart failure.

A comprehensive slide presentation with notes on the latest data examining the role of iron deficiency as a risk factor in heart failure. Evidence and recommendations for the use of intravenous iron to correct deficiencies and improve patient outcomes is presented.
PDF Download

Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1-S87. doi:10.1016/j.kint.2020.11.003

Slides from an expert interview examining the evidence around the long-term use of potassium binders to manage serum potassium levels and support treatment with guideline-directed RAASi therapy.
PDF Download

Rosano GMC, Moura B, Metra M, et al. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2021;23(6):872-881. doi:10.1002/ejhf.2206

Agarwal R, Rossignol P, Mayo MR, et al. Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes. Clin J Am Soc Nephrol. 2021;16(9):1407-1409. doi:10.2215/CJN.02890221

A clinical guide for potassium binder use and mineralocorticoid receptor antagonist dose adjustments in response to serum potassium values.
PDF Download

A comprehensive slide presentation with notes on hyperkalemia as a risk marker for poor outcomes due to under-dosing of RAASi therapy. Evidence and recommendations surrounding new strategies for managing hyperkalemia in daily practice is presented.
PDF Download

Rossignol P, David L, Chan C, Conrad A, Weir MR. Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years Compared with Data from the Clinical Trial Program. Drugs Real World Outcomes. 2021;8(3):315-323. doi:10.1007/s40801-021-00254-7

Greene SJ, Butler J, Fonarow GC. Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure-Optimizing Therapy With the Need for Speed. JAMA Cardiol. 2021;6(7):743-744. doi:10.1001/jamacardio.2021.0496

Downloadable and interactive resources for patients with heart failure including a self-management tool, symptom tracker, and questions to ask your doctor. Spanish language resources are available.

Resources to help educate patients with heart failure which include a video series, toolkit, and booklet on how to live well with heart failure.

Available in 10 languages, this website provides useful tools and videos for patients with heart failure and their caregivers.

An educational handout for patients on dietary considerations surrounding potassium and heart failure.
PDF Download